RxCelerate
Andrew Sage is a professional with extensive experience in biochemistry and biotechnology, currently serving as Team Leader at RXCELERATE LIMITED since November 2021. Prior to this role, Andrew held the position of Research Fellow at the University of Cambridge from July 2010 to November 2021, focusing on a British Heart Foundation fellowship centered on the pathogenic role of B cells in Atherosclerosis. Additionally, Andrew contributed as a Volunteer in RNA extraction at the Cambridge COVID testing centre in 2020 and completed a Postdoctoral Fellowship at UCLA Medical Center from March 2008 to July 2010. Educational credentials include a PhD in Biochemistry and a BSc in Biochemistry and Biotechnology from The University of Manchester.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!